Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.
Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.
复制标题
DOI:
10.1007/s10549-015-3303-9
复制
发表时间:
2015-02
影响因子:
3.8
通讯作者:
Okada, Morihito
中科院分区:
文献类型:
--
作者:
Aogi, Kenjiro;Kadoya, Takayuki;Sugawara, Yoshifumi;Kiyoto, Sachiko;Shigematsu, Hideo;Masumoto, Norio;Okada, Morihito
Postoperative prognosis is better for hormonal receptor-positive breast cancer than for other phenotypes; however, there are no definitive predictive factors for relapse or survival. This study aimed to evaluate the maximum standardized uptake value (SUVmax) on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography (FDG-PET/CT) and clinicopathological characteristics as possible predictors of postoperative relapse-free survival (RFS) and overall survival (OS) in hormonal receptor-positive breast cancer patients. We evaluated 262 patients with Stage I–III breast cancer diagnosed as luminal type (luminal A, 166; luminal B, 96 patients) who underwent preoperative FDG-PET/CT between January 2006 and December 2011 at two institutions. The relationships among SUVmax and clinicopathological factors (age, clinical T/N stage, nuclear grade, lymph node metastasis and vascular invasion) were evaluated. A phantom study was performed to correct differences in PET/CT analysis between two institutions. The patients were divided according to the SUVmax cutoff on receiver operating characteristic (ROC) analysis for OS (≤6.0 group vs. >6.0 group, AUC = 0.742). Clinical T-factor and nuclear grade were significantly correlated with SUVmax (p < 0.0001 and p = 0.0092, respectively). In the uni- and multivariate analyses using the Cox model for relapse, SUVmax was significant (p = 0.013 and p = 0.055, respectively) among characteristics. RFS curves showed that prognosis was significantly better for the SUVmax ≤ 6.0 group than for the SUVmax > 6.0 group (p = 0.004). Similarly, SUVmax was significant for OS (p = 0.007 and p = 0.008). OS was significantly different between the SUVmax ≤ 6.0 and >6.0 groups (p < 0.001). SUVmax was useful for predicting outcomes in patients with luminal-type breast cancer.
登录
查看更多内容
DOI:
10.1007/s002590050319
发表时间:
1998-10-01
期刊:
EUROPEAN JOURNAL OF NUCLEAR MEDICINE
影响因子:
--
作者:
Crippa, F;Seregni, E;Bombardieri, E
通讯作者:
Bombardieri, E
DOI:
10.1093/jnci/djs451
发表时间:
2012-12-19
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Groheux D;Hindié E;Delord M;Giacchetti S;Hamy AS;de Bazelaire C;de Roquancourt A;Vercellino L;Toubert ME;Merlet P;Espié M
通讯作者:
Espié M
DOI:
10.1093/jnci/djt244
发表时间:
2013-10-02
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Sestak I;Dowsett M;Zabaglo L;Lopez-Knowles E;Ferree S;Cowens JW;Cuzick J
通讯作者:
Cuzick J
影响因子:
6.2
作者:
Basu, Sandip;Chen, Wengen;Alavi, Abass
通讯作者:
Alavi, Abass
影响因子:
20.4
作者:
Berghmans, Thierry;Dusart, Michele;Sculier, Jean-Paul
通讯作者:
Sculier, Jean-Paul